AB S T R A C T In normal subjects, dietary sodium intake modulates renovascular, adrenal, and pressor responses to infused angiotensin II (AII). To examine the hypothesis that this modulation is abnormal in some patients with essential hypertension, we studied 18 hypertensives and 9 normal subjects twice-during dietary sodium restriction and during loading. Paraaminohippurate (PAH) clearance was used to assess renal plasma flow. AII was infused in graded doses (0.3-3.0 ng/kg per min). Plasma aldosterone, cortisol, renin activity, AII, sodium, potassium, and PAH clearance were measured at the onset and end of each AII dose.
INTRODUCTION
Two abnormalities in effector systems critical to volume homeostasis have been documented in some patients with essential hypertension: some show a blunted aldosterone response to a volume deficit (1, 2) and some show a renal perfusion rate that is inappropriate for the level of sodium intake (3) . The recent observation that both abnormalities occur in the same patient makes it possible that they share a common mechanism (4 volume challenge; for example, to a reduction in sodium intake (5, 6) . Sodium intake is also known to modulate the responses of both systems to AII (7) (8) (9) (10) . These observations placed a high priority on examining the responses of these two effector systems and the potential role of sodium modulation of these systems to AII in patients with essential hypertension-the subject of this study. The previous study (4) had made it clear that subgroups, rather than a continuum, were involved, and had classified the responsiveness of hypertensive patients as normal or abnormal on the basis of their adrenal response to acute stimulation on a low salt diet. The present study divided the patients according to their renovascular response to AII on a high salt diet (a condition that enhances responsiveness in normal subjects) in order to assess independently the linkage of the abnormality in these two target tissues.
METHODS
18 patients with normal-or high-renin essential hypertension and 12 normotensive subjects (age 18-45 yr) were studied on the Clinical Research Center of the Brigham and Women's Hospital. Among the hypertensives, patients with low-renin essential hypertension, defined as a plasma renin activity (PRA) response to upright posture on a 10-meq sodium diet of <2.4 ng/ml per h, were excluded (10, 11) . Each hypertensive had had outpatient diastolic blood pressure measurements >90 mmHg on at least three occasions and documented evidence of hypertension for at least 6 mo before the study. Patients with renal disease, pheochromocytoma, Cushing's syndrome, and primary aldosteronism were excluded by urinalysis, serum creatinine, plasma aldosterone, plasma norepinephrine and epinephrine, and 24-h urine vanillylmandelic acid, norepinephrine, epinephrine, and 17-hydroxycorticosteroid levels. Renovascular hypertension was excluded by normal rapid-sequence intravenous pyelograms and '34I-hippuran renograms. Two subjects underwent renal arteriography to eliminate this possibility definitively.
All antihypertensive medications were discontinued for at least 2 wk before the study. All hypertensive and nine of the normotensive subjects were fed constant isocaloric diets during their hospitalizations: one of 10-meq sodium and 100-meq potassium and the other of 200-meq sodium and 100-meq potassium. The order of diets was randomized. In some subjects, the study on diet. An intravenous catheter was placed in each of the subject's arms, one for infusion and the other for blood sampling. A control blood sample was obtained and then an 8-mg/kg loading dose of PAH was given. A constant infusion of PAH was immediately begun at a rate of 12 mg/min using an IMED pump (IMED Corp., San Diego, CA). This infusion rate achieved a plasma PAH concentration in the middle of the range in which tubular secretion dominates excretion. At this level, PAH clearance is independent of plasma concentration and, when corrected for individual body surface area, represents -90% of effective renal plasma flow. PAH clearance was calculated from the plasma concentration and the infusion rate (12, 13) . Plasma samples were obtained 45 and 60 min after the start of the constant infusion and steady state was achieved. The mean values were used for calculations.
AII infusion. After the assessment of basal PAH clearance, all subjects received an infusion of All amide (Hypertensin, Ciba-Geigy Corp., Pharmaceuticals Div., Summit, NJ) at successive doses of 0.3, 1.0, and 3.0 ng/kg per min for 45 min each, using a Harvard infusion pump (Harvard Apparatus Co., Inc., Millis, MA). The constant infusion of PAH continued throughout the All infusion to assess the changes in PAH clearance with increasing All doses. Blood pressure was monitored every 2 min with an indirect recording sphygmomanometer (Arteriosonde, Roche Diagnostics Div., Hoffmann-La Roche Inc., Nutley, NJ) with the cuff positioned over the brachial artery of the arm containing the sampling catheter. Basal blood pressure was recorded for 1 h during the basal PAH clearance study. Blood samples were drawn at the end of the control period and after each incremental infusion dose of All and analyzed for PAH, aldosterone, All, PRA, cortisol, sodium, and potassium. All hypertensive subjects and nine of the normotensive subjects received PAH and All infusions on both low and high sodium intakes.
Laboratory procedures. Blood samples were collected on ice, spun immediately, and the plasma was separated and frozen until the time of assay. Serum and urine sodium and potassium levels were measured by flame photometry, with lithium as an internal standard. Serum creatinine was measured by an autoanalyzer technique. All, aldosterone, PRA, and cortisol were assayed by radioimmunoassay techniques that have been previously described (14, 15) . Plasma PAH concentration was measured by a Technicon autoanalyzer spectrophotometric technique (12) (Technicon Instrument Corp., Tarrytown, NY).
The absolute average difference in paired PAH measurements on a single sample on the Technicon autoanalyzer on the same run is <1%. The internal standards vary by "1% or less on different days. In a group of nine normal subjects in whom duplicate determinations of PAH clearance were obtained by this method on two different days while they were ingesting the same diet, the mean PAH clearance was 638±31 ml/min per 1.73 m2. The absolute day-to-day variation was 30±39 ml/min per 1 The hypertensives included in this study were sequential admissions, and the AbR did not differ significantly from the NR with respect to age, sex, admission blood pressure, duration of hypertension, serum creatinine, or any other identifiable physiological characteristic (Table I) .
On All infusion days, there was no significant difference between the normotensive subjects, NR, and AbR in urinary sodium or potassium excretion or serum potassium concentration (Table II) . Mean kg) than the NR, this difference was not statistically significant (unpaired t test). Mean supine PRA, All, serum potassium, and diastolic blood pressure on the high or low sodium diet were not significantly different between the two groups of hypertensive patients. However, on a low sodium diet in the upright position, plasma aldosterone was significantly less (P < 0.01, FET) in the AbR (51±12 ng/dl) than in the NR (75±12 ng/dl), whereas upright All levels were similar (102±17 vs. 92±28 pg/ml, respectively). Basal All and aldosterone levels in the normotensive subjects were not significantly different from the hypertensive patients (Tables II, III) , except for basal low salt aldosterone levels in AbR, which were statistically lower (P < 0.01, unpaired t test) than in normotensive subjects (13±3 vs. 29±5 ng/dl).
Renal blood flow responses. Basal supine All levels were similar in the normotensive subjects, NR, and AbR after sodium restriction and loading. There were no statistical differences between the changes in supine plasma All concentration among the normotensive subjects, NR, and AbR on either diet at any dose of All infused (Table III) .
The NR had statistically greater decrements in renal plasma flow on a high compared with a low sodium diet at all doses of All (P < 0.001, chi-square), comparable to the responses observed in the normotensive subjects (Fig. 3) . In contrast, the responsiveness of renal plasma flow to infused All in the AbR was virtually identical on low and high sodium diets and equivalent to the responses of the normotensive subjects on a low salt intake. Basal PAH clearances among the three groups of patients were compared on a high vs. low sodium diet. Normotensive subjects and NR both had a significant increase (P < 0.01, FET) in basal PAH clearance with a high salt intake (100±23 vs. 111±17 ml/min per 1.73 mi2). In contrast, high sodium intake did not modify basal PAH clearance in the AbR (-3±22 ml/min per 1.73 M2) (Fig. 4) .
Defect in Sodium Modulation
Adrenal responses. The mean increments in plasma aldosterone in normotensives and hypertensives in response to infused AII are represented in Fig. 5 . On a low sodium diet, the NR had a significantly greater (P = 0.011, WSRT) increment in aldosterone from control during AII infusion compared with their responses on (Fig. 6) . The NR displayed the anticipated enhanced response to All on a high salt diet (P < 0.01; paired t test), but the AbR differed little from normal (Fig. 6) . Pressor responsiveness, therefore, will not be useful in delineating subgroups.
DISCUSSION
In earlier studies of essential hypertensives, a blunted adrenal response to volume challenge was associated with reduced responsiveness to All (16, 17) . A more --m_ recent study has documented that some patients with essential hypertension have a blunted adrenal and renal vascular response to volume challenge, thus suggesting that an abnormality in responsiveness to All could innilliliters per volve both the adrenal and the kidney (4). That posim restricted sibility has been documented in this study. Subjects hypertensive studied on high sodium intake, which ordinarily enormotensives hances renal vascular responsiveness, showed strikingly blunted renal blood flow responses to infused All. ANGIOTENSIN II DOSE (ng/kg/min) FIGURE 5 Mean±SEM incremental responses of plasma aldosterone to graded infusion of AII during sodium restriction (0) and loading (a) in normotensives and hypertensives. The aldosterone increment was significantly greater (P = 0.011) in the NR with sodium restriction than with sodium repletion (center panel, n = 7) comparable to normotensive subjects. The AbR showed no statistical difference between their aldosterone increments during sodium restriction and sodium repletion (right panel, n = 10). (18) . Although the AbR tended to be older, the mean age between the two groups was not statistically different. Although basal renal blood flow tends to decline with age, up to 70 yr, its responsiveness to infused All does not (18) . Adrenal responsiveness to exogenous All is also not modified by age in the age range spanned by the majority of our subjects (19) . Differences due to age alone, therefore, could not produce these findings.
Another explanation might be that the AbR have more intrinsic renal impairment or more severe hypertension than do the NR. There were, however, no easily separable clinical differences in renal function, physical examination, electrocardiograms, duration of hypertension, or admission blood pressure between the two groups of patients. The subjects were similar as judged by clinical criteria.
Other factors that might account for the blunted aldosterone response to All in the AbR are differences in serum potassium and adrenocorticotropic hormone secretion. In both groups of hypertensives, serum potassium levels were comparable and unchanged during All infusion, and plasma cortisol levels declined in the normal diurnal fashion.
Our assessment of adrenal function might be criticized because plasma aldosterone concentration was A difference in metabolic clearance rate (MCR) of aldosterone between the two groups of hypertensive subjects could lead to differences between basal and AII-stimulated aldosterone values. In addition, perhaps the All infusion itself changed the MCR of aldosterone preferentially in one group of hypertensive subjects. The latter possibility is unlikely, because All infusion alters the MCR of aldosterone similarly in essential hypertensives and normotensive controls (20) . Furthermore, in a previous study in which both plasma aldosterone and secretion rates were used to assess adrenal responsiveness, these two parameters tracked together (4). Furthermore, in the present study, the upright low salt plasma aldosterone levels were significantly different (P < 0.01, FET) in the two subgroups with similar upright plasma All levels, providing further support for a decreased adrenal response to All in the AbR. One might question whether the differences in basal levels of PAH clearance and aldosterone might determine the magnitude of responsiveness to infused All. With this possibility in mind, we further subdivided the NR and AbR and compared patients in each group with statistically indistinguishable basal sodium replete PAH clearances and sodium-restricted aldosterone levels (Table IV) . AbR had statistically lower renal blood flow (P < 0.008, FET) and aldosterone (P < 0.03, WSRT) responses to infused All than did NR matched for comparable basal levels. This analysis suggests that differences in basal renal blood flow or aldosterone between the NR and AbR cannot explain the altered tissue responsiveness to All.
Another methodologic criticism might be that steadystate plasma PAH determinations were used to assess renal blood flow uncorrected for PAH extraction by the kidney. However, renal extraction of PAH is constant until renal perfusion decreases to levels lower than those achieved with the highest doses of All infused in this study (21) , and clearly the basal levels of PAH clearance were well within the range in which extraction is unaltered. In addition, extraction of PAH by the kidney tends to be constant in the same individual, and in this study each hypertensive patient was studied serially on both diets. For these reasons, it seems acceptable to disregard PAH extraction by the kidney as significant.
None of the above criticisms, however, can account for the striking differences in renal vascular, adrenal, and blood pressure responsiveness to infused All documented in the same patients in this study. What potential mechanisms could produce these abnormalities? An abnormality in the tissue concentration of All or the All receptor are obvious candidates. An enhanced renal vascular response to converting-enzyme inhibitors has been documented in essential hypertension (22, 23) . This observation may illuminate a potential mechanism. Several investigators have observed in vitro and in vivo that vascular responsiveness to All is regulated by local or circulating All concentrations (24) (25) (26) . Thus, one possible explanation for an unresponsive renal vasculature would be an inappropriately high level of All in the kidney despite a high sodium intake. Such an inappropriately elevated intrarenal All level could account for the blunted responsiveness to exogenous All and the reduced renal blood flow response to sodium loading in the present study, as well as an enhanced response to converting-enzyme inhibition in the previous studies (22, 23) . This explanation would make it unnecessary to account for the abnormality in the renal vascular response to All on the basis of an abnormality in the All receptor or a postreceptor event. However, such an explanation would not apply to the adrenal. Clearly, the best explanation would account for abnormalities in both systems on the basis of a single defect. The most plausible candidate is that of the All receptor.
Another possible mechanism worth consideration is that the blunted responsiveness to All reflects either an abnormal amount of sodium in the body or an error in volume perception. In previous studies, the majority of normal-renin essential hypertensives in low sodium balance failed to suppress PRA and aldosterone normally with saline infusion, suggesting an error in sodium or volume perception (27, 28) . Several observations suggest that the potential defect does not reside here. Plasma volume measurements in two groups of hypertensive patients similar to the two reported in this study demonstrated no difference (4) . In the current study, basal All concentrations on a low or high sodium intake and upright All levels during sodium restriction were similar in the NR and AbR, suggesting that neither the amount of total body sodium nor its perception was central to the derangement. Finally, in normal subjects, sodium intake reciprocally influences vascular and adrenal responses to All: salt restriction blunts the vascular response, but salt loading blunts the adrenal response (7, 8) . Thus, the subnormal responsiveness of both the adrenal and renal vasculature seen in the AbR could not be accounted for on the basis of an altered sodium space or abnormal volume perception. A more plausible explanation is that these hypertensives have lost the ability to modulate responsiveness to infused All with changes in dietary sodium intake.
To determine how these abnormalities in renal blood flow and the adrenal could produce hypertension, one must examine the conditions under which the function of each is most critical. With dietary sodium loading, AbR show two differences from NR: (a) they fail to increase basal renal blood flow with the salt repletion; and (b) the absolute renal blood flow achieved is significantly less. Such differences theoretically would reduce the ability of the kidney to excrete sodium. An inability to excrete sodium appropriately might promote a volume-dependent form of hypertension. On the contrary, when dietary sodium intake is restricted in the Abr, the enhanced aldosterone response that normally facilitates sodium conservation is defective. The renin-AII-aldosterone volume feedback loop then could be closed only with excessive amounts of All. On a low salt diet, the AbR might have AII-dependent hypertension. Thus, in the same individual depending on sodium intake, the hypertension could be either All or volume dependent.
In support of the latter possibility, if hypertensives are first separated into normal-renin and high-renin subgroups, those subjects in each group with a decreased adrenal responsiveness to All have a statistically greater PRA increment with upright posture than their comparable hypertensive control group (16, 29 (29) .
If the AbR have All-dependent hypertension, one might question why their circulating PRA and All levels were not strikingly different from those of the NR. An analogy from clinical endocrinology may help to explain this observation. Proof of altered hormone production may be difficult to establish when the hormonal axis in question is evaluated in an unstimulated state. Thus, although in these hypertensives supine PRA and All may be normal, blockade of the renin-AII-aldosterone system with saralasin might help to determine whether the hypertension is All dependent. As noted above, these findings were reported previously in patients with decreased adrenal responsiveness to All (29) . Furthermore, if PRA levels are assessed after a more potent volume-depleting stimulus than used in the current study (upright posture and dietary sodium restriction), essential hypertensives with blunted adrenal responses to All do have statistically greater circulating PRA levels (16) .
This study raises an additional issue. Are the NR truly normal in their tissue responsiveness to All? Although these subjects maintain sodium modulation of their renovascular, adrenal, and pressor responses to infused All, the magnitude of their diastolic blood pressure responses is quantitatively greater than those of the normotensive controls suggesting they may not be normal. Unfortunately, the differences in pressor response to All were insufficient to use this convenient index to separate the groups.
In conclusion, this study documents that in essential hypertensives there is an abnormality in responsiveness to infused All in two systems central to volume homeostasis: the kidney and adrenal. Renovascular and adrenal responses to All and basal renal blood flow in these patients are not modified by the level of sodium intake. Fortunately, possible underlying mechanisms and the relationship of the abnormality to the hypertensive process are both amenable to direct study. 
